Immuneel is a pioneering clinical stage start-up company leading the change in cell & gene therapies & personalized immunotherapy for patients in India. Headquartered in Bengaluru, Karnataka, India, Immuneel is a research-led, fully integrated cell & gene therapies company committed to bringing breakthrough cancer treatments to India, affordably & build a portfolio of next generation cell therapies. Learn more at www.immuneel.com.
Location: India, Karnataka, Bengaluru
Employees: 11-50
Founded date: 2018
Investors 1
| Date | Name | Website |
| - | F-Prime Ca... | fprimecapi... |
Mentions in press and media 13
| Date | Title | Description |
| 21.09.2024 | The Future of Healthcare: Innovation and Collaboration at Pharmavision India 2024 | The healthcare landscape is shifting. At the forefront of this change is the 15th annual Pharmavision India conference, set to take place on September 25-26, 2024, in Ahmedabad and Hyderabad. This event is not just a gathering; it’s a cruci... |
| 18.09.2024 | Clarivate Announces 15th Annual Pharmavision India Conference Agenda | Industry leaders to discuss AI in healthcare, cell and gene therapy, market access and more at premier life sciences event LONDON, Sept. 18, 2024 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT) a leading global provider of transformative intellig... |
| 10.07.2024 | Biotech startup Immuneel Therapeutics raised Rs 100 Cr in extended Series A round | Immuneel Therapeutics is a biotech startup that focuses on cancer. Taiba Middle East FZ LLC has extended its Series A round, raising Rs 100 crore, or $12 million. The Bengaluru-based company has raised money in three rounds since its foundi... |
| 10.07.2024 | Exclusive: Kiran Mazumdar Shaw’s Immuneel Therapeutics raises Rs 100 Cr | Cancer focused biotech startup Immuneel Therapeutics has raised Rs 100 crore or $12 million in the extension of Series A round from Taiba Middle East FZ LLC. This is the third round of investment for the Bengaluru-based company since its in... |
| 10.07.2024 | Immuneel Therapeutics Raises INR 100 Cr to Expand Cancer Therapy Innovations As part of the deal, the Bengaluru-based firm providing cancer therapy will distribute up to 8,164 Series A2 Compulsorily C... | Cancer focused biotech startup Immuneel Therapeutics has announced the raising of INR 100 crore from TAIBA Middle East FZ LLC. The company has raised over USD 40 million so far, which includes the USD 15 million Series A investment that it ... |
| 21.06.2022 | Immuneel Therapeutics raises $15 million in funding | ETtechIllustration: Rahul Awasthi Immuneel Therapeutics, a biotech startup engaged in developing cell and gene therapies, has raised $15 million in Series A financing round co-led by Eight Roads Ventures, True North and F-Prime Capital, a s... |
| 21.06.2022 | Immuneel Therapeutics raises $15 million in funding | - |
| 21.06.2022 | Kiran Mazumdar-Shaw’s Immuneel Therapeutics Secures $15 Mn Funding To Scale Up Operations | The round was led by Eight Roads Ventures, True North Fund VI LLP and F-Prime Capital, with participation from other existing investors The financing will also allow us to continue building a committed and quality enterprise for global inno... |
| 21.06.2022 | Kiran Mazumdar Shaw's Co-Founded Immuneel Therapeutics Secures $15 Mn Funding | |
| 21.06.2022 | Indian cancer treatment firm raises $15m in series A round | NewsStartups Jenina Ibañez · 21 Jun 2022 · 1 min readIndian cancer treatment firm raises $15m in series A round Immuneel Therapeutics, an India-based biotech startup focused on cancer treatment, has raised US$15 million in a series A financ... |
Show more